Chargement de la fiche…
Chargement de la fiche…

Praticien hospitalier
Photo : PHGCOM, Public domain, Wikimedia Commons
Dans les médias
Vous êtes Dr Laure Gossec ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Laure Gossec est rhumatologue à Paris 13e (75651). Il consulte à GHU APHP SUN SITE PITIE SALPETRIERE, 47-83 — 47 Boulevard DE L HOPITAL, 75651 Paris 13e Arrondissement.
Consulter
GHU APHP SUN SITE PITIE SALPETRIERE
Dr Laure Gossec, c'est vous ?
Faites de cette fiche la page de votre cabinet.
47-83 — 47 Boulevard DE L HOPITAL, 75651 Paris 13e Arrondissement
Hospitalier
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine — Capacité / certificat d'études spéciales
Les plus citées
2026Annals of the rheumatic diseases73 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
2026Annals of the rheumatic diseases35 citations
EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis
2025Annals of the rheumatic diseases33 citations
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update
EULAR : PR Laure Gossec : Une vision forte pour la rhumatologie européenneSociété Française de Rhumatologie
Laure GOSSEC Les critères patient dans la PR pourquoi s'en occuperCOFER
#10 « Peurs & Croyances dans la Polyarthrite Rhumatoïde » par le Pr Laure GossecPolyarthrite Andar
Interview Pr Laure Gossec eular 2017Polyarthrite Andar
Médecin-Malade : une relation à deux ! interview Pr Laure GossecPolyarthrite AndarContenus publics où le nom du praticien apparaît (YouTube, Google Actualités).
En bref
Dr Laure Gossec consulte à GHU APHP SUN SITE PITIE SALPETRIERE, 47-83 — 47 Boulevard DE L HOPITAL, 75651 Paris 13e Arrondissement. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 01 42 16 00 00 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Paris 13e, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with active psoriatic arthritis: 52-week results from the randomised, double-blind, placebo-controlled phase 3 POETYK PsA-1 trial
2026The Journal of rheumatologyPubMed
Effect of Bimekizumab Treatment on Health Status, Work Productivity, and Productivity Costs Through 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis
2026Annals of the rheumatic diseasesPubMed
Response to correspondence on 'Final validation of the hierarchical framework for outcomes in axial spondyloarthritis: longitudinal determinants of health-related quality of life'
2026Annals of the rheumatic diseasesPubMed
Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project
2026RMD openPubMed
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
2026Annals of the rheumatic diseasesPubMed
Evaluation of pregnancy outcomes in patients with spondyloarthritis compared to the general population: results from a French national prospective and matched study
2026Annals of the rheumatic diseasesPubMed
Final validation of the hierarchical framework for outcomes in axial spondyloarthritis: longitudinal determinants of health-related quality of life
2025Annals of the rheumatic diseasesPubMed
Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomised controlled noninferiority trial
2025JMIR human factorsPubMed
Feasibility of Long-Term Physical Activity Measurement With a Wearable Activity Tracker in Patients With Axial Spondyloarthritis: 1-Year Longitudinal Observational Study
2025Rheumatology (Oxford, England)PubMed
Ultrasonography for the assessment of enthesitis in psoriatic arthritis: systematic review with meta-analysis
2025Scandinavian journal of rheumatologyPubMed
Global health in axial spondyloarthritis: thresholds for the Assessment of SpondyloArthritis international Society Health Index and the EuroQol score: analysis of the ASAS-PerSpA study
2026RMD openPubMed
Evaluation of pregnancy outcomes in patients with rheumatoid arthritis compared with the general population: results from a French national prospective and matched study
2026The Lancet. RheumatologyPubMed
Aligning approaches to rheumatoid arthritis drug development: a comparison of FDA and EMA guidance
2026Annals of the rheumatic diseasesPubMed
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
2026RMD openPubMed
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
2025Osteoarthritis and cartilage openPubMed
Greater pain and functional impairment in chronic erosive hand osteoarthritis compared to treated rheumatoid arthritis: A comparative study
2025ACR open rheumatologyPubMed
Polypharmacy in Early Rheumatoid Arthritis: Impact on Treatment Response and Adverse Event Risk in a multicenter French prospective cohort study
2025Arthritis research & therapyPubMed
Association between rapid and sustained remission and clinician- and patient-reported outcomes in patients with rheumatoid arthritis: post hoc analysis of data from the SELECT-COMPARE study
2026Rheumatology and therapyPubMed
Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS Study
2025Arthritis research & therapyPubMed
Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trials
2025RMD openPubMed
Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies
2025Rheumatology (Oxford, England)PubMed
Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOS
2026Annals of the rheumatic diseasesPubMed
Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project
2026EULAR rheumatology openPubMed
Building the future of patient-centred research: an EULAR PARE community of practice advancing patient research partner involvement in rheumatology
2026Expert opinion on biological therapyPubMed
Shared challenges in the management of difficult-to-treat chronic inflammatory diseases: expert perspectives
2026Annals of the rheumatic diseasesPubMed
The positive perspective paradigm: proposal of a model to mitigate the impact of chronic inflammatory arthritis through comprehensive and early intervention
2026EULAR rheumatology openPubMed
Artificial intelligence in healthcare faces regulatory challenges: balancing innovation with human oversight
2025Arthritis research & therapyPubMed
Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trials
2026Annals of the rheumatic diseasesPubMed
2026 EULAR updated standardised operating procedures and methods for the development of recommendations or points to consider for the diagnosis and management of people with rheumatic and musculoskeletal diseases
2025Annals of the rheumatic diseasesPubMed
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update
2026Autoimmunity reviewsPubMed
Interventions aimed at advancing gender equity in rheumatology: Insights from the Coalition for Health and Gender Equity (CHANGE) survey
2026EULAR rheumatology openPubMed
Disparities in the access to and use of biologic and targeted synthetic treatments in patients with inflammatory rheumatic and musculoskeletal diseases: a scoping review
2026 · Article
Evaluation of pregnancy outcomes in patients with rheumatoid arthritis compared with the general population: results from a French national prospective and matched study
2026 · Article
Shared challenges in the management of difficult-to-treat chronic inflammatory diseases: expert perspectives
2026 · Article
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
2026 · Article
Evaluation of pregnancy outcomes in patients with spondyloarthritis compared to the general population: results from a French national prospective and matched study
2026 · Article
Guselkumab Improves Patient-Reported Outcomes Among Participants With Psoriatic Arthritis and Inadequate Response to Tumour Necrosis Factor Inhibitors in the COSMOS Study
2026 · Article
Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis Atlas
2026 · Article
Sex Differences in Treatment Expectations, Satisfaction and Tolerance After Switching to CT-P17, an Adalimumab Biosimilar: A Post Hoc Analysis of the YU-MATTER Study
2025 · Article
Impact of Concomitant Fibromyalgia on Patient-Reported Outcomes and Inflammatory Markers in Psoriatic Arthritis: A Multinational Cross-Sectional Study
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.